Your browser doesn't support javascript.
loading
Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
Haymond, Amanda; Damluji, Abdulla A; Narayanan, Aarthi; Mueller, Claudius; Reeder, Alex; Alem, Farhang; Maxwell, G Larry; Petricoin, Emanuel F; Liotta, Lance; deFilippi, Christopher R.
  • Haymond A; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
  • Damluji AA; Inova Center of Outcomes Research, Inova Heart Vascular Institute, Falls Church, Virginia, USA.
  • Narayanan A; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA.
  • Mueller C; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
  • Reeder A; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
  • Alem F; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA.
  • Maxwell GL; Inova Center of Outcomes Research, Inova Heart Vascular Institute, Falls Church, Virginia, USA.
  • Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
  • Liotta L; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA.
  • deFilippi CR; Inova Center of Outcomes Research, Inova Heart Vascular Institute, Falls Church, Virginia, USA.
J Infect Dis ; 223(10): 1677-1680, 2021 05 28.
Article en En | MEDLINE | ID: mdl-33718952

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article